Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan Hao

Showing results (231-240 of 235) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 235 results.
Bioorganic & Medicinal Chemistry|March 24, 2026
Exploring the potential of heterocyclic-containing tail approach in the development of novel covalent inhibitors dual-targeting EGFR and HER-2: design, synthesis and biological evaluationShuang Hao, Jing-Han Yan, Rui Wang, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2025
Discovery and structural-activity relationship of N-benzyl-2-fluorobenzamides as EGFR/HDAC3 dual-target inhibitors for the treatment of triple-negative breast cancerGong-Hui Ge, Shuai Guo, Ting-Ting Li, et al.
Archiv Der Pharmazie|July 4, 2024
Discovery of 4-(isopentyloxy)-3-nitrobenzamide derivatives as xanthine oxidase inhibitors through a non-anthraquinone explorationShuai Guo, Qi Sun, Xu Zhang, et al.
Pharmacological Research|November 27, 2024
Corrigendum to "Novel deoxyhypusine synthase (DHPS) inhibitors target hypusination-induced vasculogenic mimicry (VM) against malignant melanoma" Pharmacol. Res. 209 (November) (2024) 107453Xi-He Zhao, Jian Ma, Jing-Si Guo, et al.
Pharmacological Research|October 11, 2024
Novel deoxyhypusine synthase (DHPS) inhibitors target hypusination-induced vasculogenic mimicry (VM) against malignant melanomaXi-He Zhao, Jian Ma, Jing-Si Guo, et al.
Pageof 24

Showing results (231-240 of 235) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 235 results.
Bioorganic & Medicinal Chemistry|March 24, 2026
Exploring the potential of heterocyclic-containing tail approach in the development of novel covalent inhibitors dual-targeting EGFR and HER-2: design, synthesis and biological evaluationShuang Hao, Jing-Han Yan, Rui Wang, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2025
Discovery and structural-activity relationship of N-benzyl-2-fluorobenzamides as EGFR/HDAC3 dual-target inhibitors for the treatment of triple-negative breast cancerGong-Hui Ge, Shuai Guo, Ting-Ting Li, et al.
Archiv Der Pharmazie|July 4, 2024
Discovery of 4-(isopentyloxy)-3-nitrobenzamide derivatives as xanthine oxidase inhibitors through a non-anthraquinone explorationShuai Guo, Qi Sun, Xu Zhang, et al.
Pharmacological Research|November 27, 2024
Corrigendum to "Novel deoxyhypusine synthase (DHPS) inhibitors target hypusination-induced vasculogenic mimicry (VM) against malignant melanoma" Pharmacol. Res. 209 (November) (2024) 107453Xi-He Zhao, Jian Ma, Jing-Si Guo, et al.
Pharmacological Research|October 11, 2024
Novel deoxyhypusine synthase (DHPS) inhibitors target hypusination-induced vasculogenic mimicry (VM) against malignant melanomaXi-He Zhao, Jian Ma, Jing-Si Guo, et al.
Pageof 24